BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 103 filers reported holding BIOSCRIP INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $63,000 | -70.6% | 60,500 | -18.2% | 0.00% | – |
| Q3 2016 | $214,000 | +12.6% | 74,000 | -0.5% | 0.00% | – |
| Q2 2016 | $190,000 | +458.8% | 74,362 | +368.4% | 0.00% | – |
| Q1 2016 | $34,000 | +21.4% | 15,876 | +0.1% | 0.00% | – |
| Q4 2015 | $28,000 | -6.7% | 15,863 | 0.0% | 0.00% | – |
| Q3 2015 | $30,000 | -47.4% | 15,863 | +0.1% | 0.00% | – |
| Q2 2015 | $57,000 | +470.0% | 15,851 | +620.2% | 0.00% | – |
| Q1 2015 | $10,000 | +900.0% | 2,201 | +995.0% | 0.00% | – |
| Q4 2014 | $1,000 | 0.0% | 201 | 0.0% | 0.00% | – |
| Q3 2014 | $1,000 | -50.0% | 201 | 0.0% | 0.00% | – |
| Q2 2014 | $2,000 | +100.0% | 201 | 0.0% | 0.00% | – |
| Q1 2014 | $1,000 | -97.3% | 201 | -96.0% | 0.00% | – |
| Q4 2013 | $37,000 | -15.9% | 5,000 | 0.0% | 0.00% | – |
| Q3 2013 | $44,000 | -47.0% | 5,000 | 0.0% | 0.00% | – |
| Q2 2013 | $83,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coliseum Capital Management, LLC | 5,622,410 | $5,847,000 | 2.64% |
| NORTH TIDE CAPITAL, LLC | 8,500,000 | $8,840,000 | 1.51% |
| WYNNEFIELD CAPITAL INC | 3,700,000 | $3,848,000 | 1.39% |
| Alta Fundamental Advisers LLC | 2,330,774 | $2,424,000 | 1.20% |
| ARDSLEY ADVISORY PARTNERS LP | 6,350,000 | $6,604,000 | 1.09% |
| Camber Capital Management LP | 10,180,000 | $10,587,000 | 0.55% |
| PERKINS CAPITAL MANAGEMENT INC | 298,000 | $310,000 | 0.34% |
| Hawk Ridge Capital Management | 340,429 | $354,000 | 0.18% |
| Eidelman Virant Capital | 220,000 | $228,000 | 0.13% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 227,280 | $236,000 | 0.11% |